Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140556
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2005-08-29
Brief Title:
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Sponsor:
David M Brizel MD
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00008840
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
David M Brizel MD
Lead Sponsor Class:
OTHER
Responsible Party:
David M Brizel MD
Responsible Party Title:
Professor Radiation Oncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| OSI Pharmaceuticals | INDUSTRY |
| Genentech Inc | INDUSTRY |